tci Medicare Compliance & Reimbursement - 2021 Issue Q3

Industry Notes: Feds Add $3 Billion to Next-Gen COVID Therapy Research Coffers

The government continues to promote COVID-19 vaccination as the best bet to thwart the virus, but the feds also want to study and develop antiviral therapies, too. Read on for the latest news. Then: In March, President Biden signed the American Rescue Plan Act (ARPA) into law, allocating billions for COVID-related tracing, testing, vaccinations, and research (see Medicare Compliance & Reimbursement, Vol. 47, No. 6). Now: On June 17, the Department of Health and Human Services (HHS) announced that the feds would be “investing more than $3 billion to accelerate the discovery, development and manufacturing of antiviral medicines...

To read the full article, sign in and subscribe to tci Medicare Compliance & Reimbursement.


Keep pace with evolving Medicare regulations — and onboard your team — with timely analysis of critical updates interpreted in an easy-to-follow, easy-to-apply format. Your subscription to TCI's Medicare Compliance & Reimbursement Alert will equip you to navigate code and guideline changes, CCI edits, and revisions to modifiers, payer policies, the fee schedule, OIG target areas, and more.

  • Current newsletters added each month
  • Fully searchable archives - over 4200 articles
  • ALL years/issues back to 2003 organized by year and issue
  • Codes mentioned in articles are linked to Code Information pages
  • Code Information pages link back to related articles
Access to this feature is available in the following products:
  • tci Medicare Compliance & Reimbursement +Archives

demo
request yours today
 subscribe
start today
 newsletter
free subscription

Thank you for choosing Find-A-Code, please Sign In to remove ads.